A role for caspase‐2 in sphingosine kinase 1 proteolysis in response to doxorubicin in breast cancer cells – implications for the CHK1‐suppressed pathway

By  

FEBS Open Bio, Vol. 8, Iss. 1, 2018-01 ,pp. : 27-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

2ME and 2OHE2 exhibit growth inhibitory effects and cell cycle arrest at G2/M in RL95-2 human endometrial cancer cells through activation of p53 and Chk1

By Gong Qian-fen   Liu E-hu   Xin Rong   Huang Xiuning   Gao Ning  

Molecular and Cellular Biochemistry, Vol. 352, Iss. 1-2, 2011-06 ,pp. : 221-230

Springer Publishing Company

Access to resources Recommend Favorite

Cyclin B1 is an efficacy-predicting biomarker for Chk1 inhibitors

By Xiao Zhan   Xue John   Gu Wen-Zhen   Bui Mai   Li Gaoquan   Tao Zhi-Fu   Lin Nan-Horng   Sowin Thomas   Zhang Haiying  

Biomarkers, Vol. 13, Iss. 6, 2008-09 ,pp. : 579-596

Informa Healthcare

Access to resources Recommend Favorite

The ATR-Chk1 pathway plays a role in the generation of centrosome aberrations induced by Rad51C dysfunction

By Katsura Mari   Tsuruga Takanori  

Nucleic Acids Research, Vol. 37, Iss. 12, 2009-07 ,pp. : 3959-3968

Oxford University Press

Access to resources Recommend Favorite

MEPE/OF45 protects cells from DNA damage induced killing via stabilizing CHK1

By Liu Shuang  

Nucleic Acids Research, Vol. 37, Iss. 22, 2009-12 ,pp. : 7447-7454

Oxford University Press

Access to resources Recommend Favorite